Stay up to date with our newsletter

Get in touch!

To explore career opportunities with Sai Life Sciences, share your CV here.

Lets start the conversation!

Sign up to our newsletter

Thank you!
We will be in touch shortly.

2024.02.08

A scenic view of Sai Life Sciences' Integrated Discovery & Development Campus in Hyderabad, featuring modern research buildings, a lush green landscape, and a serene water body with floating lily pads, symbolizing the company’s commitment to sustainability and eco-friendly operations.

Sai Life Sciences releases its Sustainability Report 2023

Sai Life Sciences, a leading global Contract Research, Development & Manufacturing Organization (CRO/ CDMO), released its Sustainability Report 2022-2023. Developed in accordance with the Global Reporting Initiative (GRI) Universal Standards 2021 framework, the fourth edition of the Sustainability report is based on the theme ‘Steadfast on Sustainability,’ and it articulates the company’s commitment to sustainability and the journey so far. Read the full report here.

Making this announcement, Krishna Kanumuri, CEO & Managing Director, stated, “I am delighted to present our fourth successive Sustainability Report, reflecting our commitment to the sustainability journey and to conduct our business responsibly. In 2023, we reset our Sustainable Development Goals to attain specific Environmental, Social, and Governance (ESG) targets by March 31, 2027. The learnings and insights gleaned from our previous experience have shaped our SDGs for this phase, reflecting confidence in our ability to strive for and achieve more ambitious targets.”

The fourth report released by Sai Life Sciences highlights significant progress in various areas:

Environmental:

  • Joined the Science Based Targets initiative (SBTi), a global body enabling businesses to set ambitious emission reduction targets in line with the latest climate science. Accordingly, the company has committed to set near-term company-wide emission reductions in line with climate science with the SBTi.
  • Joined the Sustainable Markets Initiative (SMI) of Manufacture 2030, fostering collaboration with the company’s pharma partners to implement tangible measures for decarbonizing healthcare supply chains.

Social:

  • Strengthened the company’s commitment to social accountability through the implementation of robust policies addressing labor and human rights. Nurtured an agile workforce by embracing diversity across age and gender at all management levels, with dedicated efforts toward empowering women throughout the organization.

Governance:

  • Established the 'Sustainability Governance Council' to seamlessly integrate sustainability matters into the company’s business strategy and oversee the effective enforcement of the sustainability mandate.

This report underscores the company’s dedication to sustainability and exemplifies the progress made, reinforcing Sai Life Sciences' position as a frontrunner in the pursuit of environmentally conscious and socially responsible business practices.

Share article

More News

2025.02.07

Sai Life Sciences headquarters, symbolizing innovation and growth, featured in a blog post about the company's strong quarterly report performance.

Sai Life Sciences Limited reports robust quarterly results

Revenue grows by 15%; Net Profit up 36% year-on-year Sai Life Sciences Limited (BSE: 544306 I NSE: SAILIFE), an innovator focused, Contract Research and Development Organization (CRDMO) today announced its financial results for the third quarter and nine months ended December 31, 2024. Financial Performance: Particulars (₹ crores) Q3FY25 Q3FY24 YoY% 9MFY25 9MFY24 YoY% Revenue […]
Read more

2025.01.01

Before and after comparison of the historic Manchirevula stepwell restoration by Sai Life Sciences, showcasing transformation from a neglected site to a well-maintained water body near a temple.

Sai Life Sciences completes restoration of historic Manchirevula stepwell

As part of its Corporate Social Responsibility (CSR) initiative, Sai Life Sciences, in collaboration with the Society for Advancement of Human Endeavours (SAHE), completed the restoration of the historic stepwell dating back to the 17th century at the Sri Venugopala Swamy temple premises, located in Manchirevula, Hyderabad. The Manchirevula Stepwell Restoration Project was undertaken with […]
Read more

2024.10.28

Advanced manufacturing facility at Sai Life Sciences, showcasing state-of-the-art equipment and quality control, featured in a blog post about receiving Establishment Inspection Reports (EIRs) from the USFDA.

Sai Life Sciences receives EIRs from USFDA for India R&D & Manufacturing facilities

Sai Life Sciences, the fastest-growing Indian Contract Research, Development and Manufacturing Organization (CRDMO)[1], announced that it has received Establishment Inspection Reports (EIR) from the US Food and Drug Administration (USFDA) for its R&D (Unit II, Hyderabad), and Manufacturing (Unit IV, Bidar) sites in India. The General Good Manufacturing Practices (GMP) audit was conducted at the […]
Read more

2024.10.07

Sai Life Sciences' eco-friendly campus with green landscaping and modern architecture at sunset, featured in a blog post about the company's 2024 Sustainability Report

Sai Life Sciences releases Sustainability Report 2024

Sai Life Sciences, the fastest-growing Indian Contract Research, Development and Manufacturing Organization (CRDMO)[1], published its Sustainability Report for 2023-2024. Aligned with the Global Reporting Initiative (GRI) Universal Standards 2021 framework, this fifth edition of the Sustainability Report is based on the theme, ‘Synergising Sustainability, Performance and Growth.’ The full report can be read here. Making […]
Read more

2024.08.09

Sai Life Sciences scientist accessing a -40.2°C ultra-low temperature storage unit as part of the advanced Compound Management process, enhanced by the in-house CORAL software application.

Sai Life Sciences elevates Compound Management process with in-house software application, CORAL

Compound management is a vital function in pharmaceutical research. A streamlined environment can bring significant value to the process in the form of productivity and efficiency. Recognizing the importance of this function, we have made our Compound Management suite for Discovery services smarter with the introduction of an in-house software application, Compound Organization and Registration […]
Read more